INTERNATIONAL PATENT: INXMED (NANJING) CO., LTD., 应世生物科技（南京）有限公司 FILES APPLICATION FOR "ANTIBODY TARGETING CD105 OR ANTIGEN-BINDING FRAGMENT THEREOF AND USE THEREOF"

GENEVA, March 8 -- INXMED (NANJING) CO., LTD. (3rd Floor, Block D-2, 73 Tanmi Road, Jiangbei New DistrictNanjing, Jiangsu 210000), 应世生物科技（南京）有限公司 (中国江苏省南京市江北新区探秘路73号树屋十六栋D-2栋3层) filed a patent application (PCT/CN2024/114814) for "ANTIBODY TARGETING CD105 OR ANTIGEN-BINDING FRAGMENT THEREOF AND USE THEREOF" on Aug 27, 2024. With publication no. WO/2025/045032, the details related to the patent application was published on Mar 06, 2025.

Notably, the patent application was submitted under...